Zymeworks BC Inc (NASDAQ: ZYME) kicked off on Tuesday, down -2.70% from the previous trading day ,before settling in for the closing price of $9.62. Over the past 52 weeks, ZYME has traded in a range of $6.01-$13.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 264.10% over the last five years. While this was happening, its average annual earnings per share was recorded 43.22%. With a float of $65.91 million, this company’s outstanding shares have now reached $70.12 million.
The firm has a total of 277 workers. Let’s measure their productivity.
Zymeworks BC Inc (ZYME) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Zymeworks BC Inc is 7.46%, while institutional ownership is 91.46%. The most recent insider transaction that took place on Jan 08 ’24, was worth 63,996. In this transaction Chair & CEO of this company sold 5,706 shares at a rate of $11.22, taking the stock ownership to the 23,762 shares. Before that another transaction happened on Jan 08 ’24, when Company’s Chief Scientific Officer sold 2,339 for $11.22, making the entire transaction worth $26,233. This insider now owns 7,367 shares in total.
Zymeworks BC Inc (ZYME) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/30/2023, the organization reported -$0.2 earnings per share (EPS), higher than consensus estimate (set at -$0.43) by $0.23. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.00% during the next five years compared to -6.52% drop over the previous five years of trading.
Zymeworks BC Inc (NASDAQ: ZYME) Trading Performance Indicators
Take a look at Zymeworks BC Inc’s (ZYME) current performance indicators. Last quarter, stock had a quick ratio of 7.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.74, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -0.10 in one year’s time.
Technical Analysis of Zymeworks BC Inc (ZYME)
Analysing the last 5-days average volume posted by the [Zymeworks BC Inc, ZYME], we can find that recorded value of 0.47 million was lower than the volume posted last year of 0.57 million. As of the previous 9 days, the stock’s Stochastic %D was 28.98%. Additionally, its Average True Range was 0.49.
During the past 100 days, Zymeworks BC Inc’s (ZYME) raw stochastic average was set at 33.92%, which indicates a significant increase from 13.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.60% in the past 14 days, which was lower than the 46.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.08, while its 200-day Moving Average is $8.81. Now, the first resistance to watch is $9.64. This is followed by the second major resistance level at $9.91. The third major resistance level sits at $10.18. If the price goes on to break the first support level at $9.10, it is likely to go to the next support level at $8.83. Should the price break the second support level, the third support level stands at $8.56.
Zymeworks BC Inc (NASDAQ: ZYME) Key Stats
The company with the Market Capitalisation of 666.62 million has total of 70,568K Shares Outstanding. Its annual sales at the moment are 76,010 K in contrast with the sum of -118,670 K annual income. Company’s last quarter sales were recorded 16,930 K and last quarter income was -14,480 K.
